Zhujun Yin

Translational Chinese Medicine Key Laboratory Of Sichuan Province
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Natural Polyphenol Pentagalloyl Glucose as a Potent Xanthine Oxidase Inhibitor for Hyperuricemia Treatment.

Natural Polyphenol Pentagalloyl Glucose as a Potent Xanthine Oxidase Inhibitor for Hyperuricemia Treatment.

Journal: Journal of agricultural and food chemistry

Published: August 23, 2025

Tetrahydrocurcumin alleviates colorectal tumorigenesis by modulating the SPP1/CD44 axis and preventing M2 tumor-associated macrophage polarization.

Tetrahydrocurcumin alleviates colorectal tumorigenesis by modulating the SPP1/CD44 axis and preventing M2 tumor-associated macrophage polarization.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 17, 2025

Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys.

Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys.

Journal: Frontiers in pharmacology

Published: October 25, 2024

Recent nanoengineered therapeutic advancements in sepsis management.

Recent nanoengineered therapeutic advancements in sepsis management.

Journal: Frontiers in bioengineering and biotechnology

Published: September 18, 2024

The role of tetrahydrocurcumin in disease prevention and treatment.

The role of tetrahydrocurcumin in disease prevention and treatment.

Journal: Food & function

Published: June 05, 2024

Innovative design concepts in tumor-targeting peptide-drug conjugates: Insights into emerging applications.

Innovative design concepts in tumor-targeting peptide-drug conjugates: Insights into emerging applications.

Journal: Chinese medical journal

Published: April 24, 2024

LC-MS-based metabolomics reveals the mechanism of anti-gouty arthritis effect of Wuwei Shexiang pill.

LC-MS-based metabolomics reveals the mechanism of anti-gouty arthritis effect of Wuwei Shexiang pill.

Journal: Frontiers in pharmacology

Published: April 28, 2023

Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.

Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.

Journal: Frontiers in pharmacology

Published: February 13, 2023

Novel Leflunomide Analog, UTLOH-4e, Ameliorates Gouty Arthritis Induced by Monosodium Urate Via NF-κB/NLRP3 Signaling Pathway.

Novel Leflunomide Analog, UTLOH-4e, Ameliorates Gouty Arthritis Induced by Monosodium Urate Via NF-κB/NLRP3 Signaling Pathway.

Journal: Current pharmaceutical biotechnology

Published: July 07, 2022

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin.

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin.

Journal: Frontiers in pharmacology

Published: July 04, 2022

Mechanism Investigation of Wuwei Shexiang Pills on Gouty Arthritis via Network Pharmacology, Molecule Docking, and Pharmacological Verification.

Mechanism Investigation of Wuwei Shexiang Pills on Gouty Arthritis via Network Pharmacology, Molecule Docking, and Pharmacological Verification.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: June 23, 2022

Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Journal: Frontiers in pharmacology

Published: September 27, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026